| 摘要 |
A method of treating loss of brain function in a patient comprising the steps of preparing a composition comprising a D peptide and a pharmaceutically acceptable carrier. The D peptide has the general structure: A-B-C-D-E-F-G-H in which
A is Ala, or absent,B is Ser, Thr or absent,C is Ser, Thr or absent,D is Ser, Thr, Asn, Glu, Arg, Ile, Leu,E is Ser, Thr, Asp, Asn,F is Thr, Ser, Asn, Arg, Gln, Lys, Trp,G is Tyr, andH is Thr, Ser, Arg, Gly.
All amino acids in the D peptide are the D stereoisomeric configuration. The peptide composition is administered in a therapeutically effective dose. |
| 主权项 |
1. A method of treating loss of brain function in a patient comprising the steps of:
preparing a composition comprising a D peptide and a pharmaceutically acceptable carrier,
said D peptide further comprises the general structure: A-B-C-D-E-F-G-H in which: A is Ala, or absent, B is Ser, Thr or absent, C is Ser, Thr or absent, D is Ser, Thr, Asn, Glu, Arg, Ile, Leu, E is Ser, Thr, Asp, Asn, F is Thr, Ser, Asn, Arg, Gln, Lys, Trp, G is Tyr, and H is Thr, Ser, Arg, Gly, and wherein all amino acids are the D stereoisomeric configuration, and administering said composition to the patient in a therapeutically effective dose, wherein said composition acts to treat the loss of brain function in the patient. |
